5 Stocks Going Ex-Dividend Tomorrow: XLS, NEU, BCE, FIS, MO

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Tomorrow, March 13, 2013, 88 U.S. common stocks are scheduled to go ex-dividend. The dividend yields on these stocks range from 0.2% to 15.8%. All of these stocks can be found on our stocks going ex-dividend section of our dividend calendar.

Highlighted Stocks Going Ex-Dividend Tomorrow:

Exelis

Owners of Exelis (NYSE: XLS) shares as of market close today will be eligible for a dividend of 10 cents per share. At a price of $11.04 as of 9:36 a.m. ET, the dividend yield is 3.7%.

The average volume for Exelis has been 1.0 million shares per day over the past 30 days. Exelis has a market cap of $2.1 billion and is part of the telecommunications industry. Shares are down 2.6% year to date as of the close of trading on Monday.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys dividend stocks that have the potential for a 3% to 4% yield and 10% growth. Get his best picks for less than $50/year.

Exelis Inc. provides command, control, communications, computers, intelligence, and surveillance and reconnaissance (C4ISR) related products and systems in the United States and internationally. The company has a P/E ratio of 6.35. Currently there is 1 analyst that rates Exelis a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Exelis as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and poor profit margins. You can view the full Exelis Ratings Report now.

If you liked this article you might like

'Mad Money' Lightning Round: Buy, Buy, Buy Rite Aid for the Long Term

Jim Cramer's 'Mad Money' Recap: Time to Do Some Buy, Buy, Buying

Harris' Weak Results Vindicate Its Aggressive M&A Strategy

Jim Cramer's Top Takeaways: Harris, Lululemon Athletica, Tesla

Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference